Drug
SR 48968 clinical trials
Also written Saredutant.
How studies write it
Studies that test it under each name
Name
Other names
Studies by the year they started
8 studies that test it; most in 2006 (5)
| Year | Studies |
|---|---|
| 2006 | 5 |
| 2007 | 2 |
| 2008 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 3
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses SR 48968 is read from its arms, and is right about nine times in ten.
Testing it · 8
- An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive DisorderCompletedPhase 3SanofiNCT00629551Written as saredutant (SR48968)
- An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive DisorderCompletedPhase 3SanofiNCT00531622Written as saredutant (SR48968)
- An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety DisorderCompletedPhase 3SanofiNCT00417118Written as Saredutant
- An Eight-week Study to Evaluate the Efficacy and Safety of 2 Doses of Saredutant in Patients With Generalized Anxiety DisorderCompletedPhase 3SanofiNCT00390533Written as Saredutant
- An Eight-week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive DisorderCompletedPhase 3SanofiNCT00415142Written as saredutant (SR48968)
- A 24-52-week Study to Evaluate the Long-term Efficacy and Safety of Saredutant in Patients With Depression (MAGENTA)CompletedPhase 3SanofiNCT00336713Written as Saredutant (SR48968C)
- A Study Evaluating the Safety and Tolerability of Abrupt Discontinuation of Saredutant in Patients With DepressionCompletedPhase 3SanofiNCT00429260Written as Saredutant
- A North-American Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety DisorderCompletedPhase 3SanofiNCT00390650Written as Saredutant
Codes
What other systems call SR 48968 · ClinicalTrials.gg INT003625
- MeSH (NLM) C073839SR 48968One source NLM
- UNII (FDA) 720U2QK8I5SAREDUTANTConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C073839 | SR 48968 | One source NLM |
| UNII (FDA) | 720U2QK8I5 | SAREDUTANT | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.